Navigation Links
KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
Date:8/28/2007

Technology to be Applied to Both Clinical- and Preclinical-Stage Compounds

in Merck KGaA Pipeline

EMERYVILLE, Calif., Aug. 28 /PRNewswire/ -- KineMed, Inc., a pathway-based drug discovery and development company, announced today that it will collaborate with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, to discover new applications for drug candidates. KineMed's proprietary pathway-based drug discovery and development technology identifies compounds that can modulate key metabolic pathways present in both preclinical animal models and in humans. By measuring real-time activity of drugs against these targeted pathways, KineMed's technology reduces development risk by selecting drug candidates with the best potential to demonstrate clinical efficacy and confirm desired drug activity in first-in-man studies.

In the collaboration, KineMed will identify new therapeutic utility in in vivo preclinical models by applying its proprietary translational medicine technologies. Once a disease target is established for a selected drug candidate, KineMed and Merck KGaA will jointly determine the best development and commercialization path for the development candidates being studied.

Under the terms of the agreement, KineMed will receive from Merck an upfront payment, milestones and royalty payments on products advanced with KineMed's technology. Additional terms of the deal were not disclosed.

David Fineman, President and CEO of KineMed, commented, "We are pleased to expand our relationship with Merck KGaA into this broader development collaboration. Our technology uniquely enables our partners to screen development candidates against KineMed's dynamic targets of pathway kinetics. Partnering with KineMed further enables its partners to rapidly demonstrate on-mechanism dose response in first-in-man studies with KineMed's unique translational medicine capabilities."

Mr. Fineman continued, "In this collabo
'/>"/>

SOURCE KineMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. GE, St. Jude to collaborate on visualization technology
2. GE Healthcare, MobileAccess to collaborate on hospital wireless
3. GE Healthcare, Harvard medical school to collaborate on nervous system research
4. Madison, Milwaukee med schools to collaborate on tech transfer
5. EraGen collaborates with Emory University on HIV detection system
6. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
7. Silencer Validated siRNAs
8. Using Validated siRNAs in Functional Genomic Assays
9. YOUR DATA: Direct Real-time RT-PCR on Sympathetic Neuron Lysates Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs
10. YOUR DATA: Direct Real-time RT-PCR on Sympathetic Neuron Lysates Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs
11. Stem cell bank announcement validates quality of Wisconsin research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...test pilots push planes to explore their limits, r...and Technology (NIST) are probing the newest micro...curacy at the nanoscale. Better nanoscale measurem...ing production in the semiconductor and nanomanufa...logy uses helium ions to generate the signal used ...
(Date:9/5/2008)...e Food & Drug Administration (FDA) issued in July ...port acknowledged that nanoscale materials potenti... by the agency and that those materials present ch...elevant to product safety and effectiveness may ch...icipating the potential for rapid commercializatio...
(Date:9/5/2008)...us, gold is only valuable if we possess it in larg...le isn,t the case for those interested in exploiti...ariety of chemical reactions, including the oxidat...s carbon dioxide at room temperatures. That proces...e effectiveness of catalytic converters that clean...
(Date:9/5/2008)...ept. 5 /- Gen-Probe Incorpo...mpany will present at the Morgan,Stanley Global He...r 9,2008 at approximately 2:45 p.m. Eastern Time....and may be accessed through a link on the investor...n-probe.com . The webcast,will be available for 30...
Breaking Biology Technology:NIST studies how new helium ion microscope measures up 2Nanotechnology and the FDA: size matters 2NIST and partners identify tiny gold clusters as top-notch catalysts 2Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference 2
... United States may rank a lowly 16 th in broadban... has decided to be in the forefront. , ,Following ...Broadband Deployment Act, the state aims to extend...ructure" to rural and other underserved areas. Gov...roviding tax incentives to qualified companies who...
...wo of the largest U.S.-based multi-national corpor...ee County Research Park . , , Johnson Controls an...k, according to Dave Domres, vice president of ass...C . , ,Johnson Controls, a Milwaukee-based facili...anufacturer of automotive systems, plans to open a...
..., we looked at the leading pharmaceutical companie...rket, which for the first time surpassed $600 bill...quation, as another significant market is the med...rs on the size of the total medical device market ...illion in annual revenue in 2005, as the top 20 me...
... Lou Tornatzky, co-author of a white paper that sp...kee,s economy, said the city has all the pieces in... , ,Tornatzky, who will present his ideas here dur...nnovation Network , said Milwaukee has even more i... technology locales when they began their economic...
Other Biology Technology:Roll out the broadband 2Midwest retains dominant role in 2005 world medical device market 2Midwest retains dominant role in 2005 world medical device market 3Midwest retains dominant role in 2005 world medical device market 4Midwest retains dominant role in 2005 world medical device market 5Midwest retains dominant role in 2005 world medical device market 6Midwest retains dominant role in 2005 world medical device market 7Innovation expert says Milwaukee has all the tools 2Innovation expert says Milwaukee has all the tools 3Innovation expert says Milwaukee has all the tools 4
(Date:9/5/2008)...nformatics will convene September 7-9 at the Stock...ging neuroinformatics field combines neuroscience ... and approaches to understanding the structure and...ied to brain disorders and diseases. With a broad ...ether experts from all disciplines contributing to...
(Date:9/5/2008)... face the challenge of surviving in a changing cli...niversit Claude Bernard Lyon have shown how a shee... of Scotland responds to two consequences of clima...dictability of winter storms. Dr. Thomas Ezard, le...good and food is plentiful, lambs contribute almos...
(Date:9/5/2008)... Hurricane Gustav is shown via a sequence of satel...n Imaging Spectrometer (MERIS) instrument on 25 Au...rom right to left). , Gustav formed on 25 August...ti (seen above far right image), when a tropical w...feature (visible), causing the U.S. National Hurri...
(Date:9/4/2008)....D. Anderson Cancer Center have developed a risk p...for African Americans that suggests a greater risk..., according to a report published in the September...of the American Association for Cancer Research. ...rican Americans with lung cancer and 497 African A...
Breaking Biology News(10 mins):INCF organizes the first congress dedicated to the emerging field of neuroinformatics 2Hurricane Gustav 2African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease 2Manipulating the immune system like a parasite 16341 1Manipulating the immune system like a parasite 16341 2Alsius Corporation Awarded Three Year Agreement With MedAssets Supply Chain Systems 16338 1Alsius Corporation Awarded Three Year Agreement With MedAssets Supply Chain Systems 16338 2Alsius Corporation Awarded Three Year Agreement With MedAssets Supply Chain Systems 16338 3Nuvelo Announces Presentations on NU206 and rNAPc2 at 2008 American Association for Cancer Research Annual Meeting 16333 1Nuvelo Announces Presentations on NU206 and rNAPc2 at 2008 American Association for Cancer Research Annual Meeting 16333 2New Therapy by Merck is Positioned to Earn Gold Standard Status by 2011 in the Treatment of Chemotherapy Induced Nausea and Vomiting 4489 1New Therapy by Merck is Positioned to Earn Gold Standard Status by 2011 in the Treatment of Chemotherapy Induced Nausea and Vomiting 4489 2New Therapy by Merck is Positioned to Earn Gold Standard Status by 2011 in the Treatment of Chemotherapy Induced Nausea and Vomiting 4489 3
...d a new molecule that inhibits proliferation of a ...tro and in vivo. The findings, published in the Ma...nase family members are most likely to play a role...concept that successful small molecule kinase inhi...ely attenuate the complex signaling pathways invol...
...sts has synthesized a new compound that dramatical...rating stroke symptoms. The research appears as th...ournal of Biological Chemistry, an American Societ..., Stroke is the third leading cause of death in th... disability. An ischemic stroke occurs when a cere...
...ng studies, brain scientists at Carnegie Mellon Un...covered that the anatomical differences that chara...ed to the way those brains process information. ...e of synchronization among activated brain areas i...he corpus callosum, the white matter that acts as ...
... colleagues at St George,s, University of London, ...om entering the body, so rendering them harmless. ...tly shortlisted for the Northwest Regional Develop...completely new approach to the treatment and preve...n our earlier discovery of how allergens, the subs...
Other Biology News:Unique dual target specificity of kinase inhibitor key for success against cancer 2New compound reduces stroke damage 2Carnegie Mellon researchers discover key deficiencies in brains of people with autism 2Carnegie Mellon researchers discover key deficiencies in brains of people with autism 3Allergy battle could be won in five years, says scientist 2
...Maker, 1. Modular system for large format and medi...b-cast or precast gels (26 x 20 cm) simultaneously...mple-to-use 1.0-mm or 1.5-mm pre-assembled hinged ... and unloading.Built-in ceramic heat exchanger and...
Edited by P.J. Delves (1997) An up-to-date review of antibody-raising technologies, this volume provides researchers with immediate access to the protocols they require every day.
Request Info
MOUSE ANTI HUMAN FACTOR I
Biology Products: